Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL444014 | 1.00 | KDM4E (0.48) | KDM4EPDE4ALMNAL3MBTL1TDP1 | |
| SCHEMBL10299846 | 1.00 | KDM4E (0.48) | KDM4EPDE4ALMNAL3MBTL1TDP1 | |
| Hydrochloric Acid SCHEMBL8528184 | 0.98 | KDM4E (0.47) | KDM4EPDE4ALMNAL3MBTL1TDP1 | |
| SCHEMBL25262519 | 0.82 | PDE4A (0.42) | KDM4EPDE4ALMNAL3MBTL1TDP1 | |
| SCHEMBL10299778 | 0.80 | PDE4A (0.41) | KDM4EPDE4ALMNAL3MBTL1TDP1 | |
| SCHEMBL11350754 | 0.80 | PDE4A (0.41) | KDM4EPDE4ALMNAL3MBTL1TDP1 | |
| SCHEMBL8532266 | 0.80 | PDE4A (0.41) | KDM4EPDE4ALMNAL3MBTL1TDP1 | |
| SCHEMBL16201531 | 0.80 | PDE4A (0.41) | KDM4EPDE4ALMNAL3MBTL1TDP1 | |
| SCHEMBL11414474 | 0.80 | PDE4A (0.41) | KDM4EPDE4ALMNAL3MBTL1TDP1 | |
| SCHEMBL8829389 | 0.79 | PDE4A (0.43) | KDM4EPDE4ALMNAL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190209647-A1 | COMPOSITIONS FOR THE TREATMENT OF INTESTINAL DISORDERS | DEVINTEC SAGL (CH) | 2019-07-11 | — | — | US | disclosed |
| US-5844103-A | Anionic glycasuccinamide sufactants and a process for their manufacture | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1998-12-01 | — | — | US | disclosed |
| US-5786468-A | NONIONIC SURFACTANTS DERIVED FROM CARBOHYDRATES FOR SHAMPOO, DEODORANTS OR CLEANING COMPOUNDS | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1998-07-28 | — | — | US | disclosed |
| US-5750733-A | Hydroxy containing alkyl glycamides, low foaming detergent compositions comprising such and a process for their manufacture | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1998-05-12 | — | — | US | disclosed |
| US-5631389-A | SUCCINAMIDES WITH SUGAR GROUPS, POLLUTION CONTROL, BIODEGRADABLE | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1997-05-20 | — | — | US | disclosed |
| US-5541341-A | CARBOHYDRATE BASED SURFACTANTS | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1996-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190209647-A1 | COMPOSITIONS FOR THE TREATMENT OF INTESTINAL DISORDERS | SI, MUC1, FABP2 | KDM4E 3717/4885PDE4A 1844/4885LMNA 3219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.